FDA Inspection 1235872 — Prof. Dae Ho Lee
The FDA completed an inspection of Prof. Dae Ho Lee on Mar 8, 2024 in Songpa District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Songpa District (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)